Ansa Biotechnologies

company

About

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Biotechnology,Life Science,Therapeutics
Founded date
May 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerate innovation in biological research and engineering.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.21M
Ansa Biotechnologies has raised a total of $1.21M in funding over 2 rounds. Their latest funding was raised on Apr 9, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 9, 2021 Grant $0.99M 1 National Science Foundation Detail
Jun 19, 2019 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Ansa Biotechnologies is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant